Bristol-Myers Squibb Company
BMY● 市場休市$62.88-1.57%
Healthcare
Bristol-Myers Squibb Company operates as a global biopharmaceutical entity, actively involved in the research, development, licensing, production, and worldwide commercialization of its medicinal portfolio. The company's therapeutic areas span hematology, oncology, cardiovascular health, immunology, fibrotic conditions, neuroscience, and infectious diseases like COVID-19.
價格圖表
右方向鍵：此組的更多工具
右方向鍵：此組的更多工具
右方向鍵：此組的更多工具
右方向鍵：此組的更多工具
右方向鍵：此組的更多工具
右方向鍵：此組的更多工具
右方向鍵：此組的更多工具
載入圖表中…
概覽
形態分析 (Basic+)
K線形態識別在 Basic 及以上方案中可用。 升級
關於 Bristol-Myers Squibb Company
Bristol-Myers Squibb Company（BMY）屬於 Healthcare 板塊（Drug Manufacturers - General）。 該股在 NYSE 上市。 市值：$1284億。 52 周區間：$42.52 – $68.64。
Bristol-Myers Squibb Company operates as a global biopharmaceutical entity, actively involved in the research, development, licensing, production, and worldwide commercialization of its medicinal portfolio. The company's therapeutic areas span hematology, oncology, cardiovascular health, immunology, fibrotic conditions, neuroscience, and infectious diseases like COVID-19.
閱讀更多
Its significant pharmaceutical offerings include Revlimid, an oral immunomodulatory agent for multiple myeloma, and Eliquis, an oral anticoagulant crucial for reducing stroke risk and systemic embolism in non-valvular atrial fibrillation, as well as treating deep vein thrombosis and pulmonary embolism.
The portfolio also features Opdivo, utilized across various anti-cancer indications; Pomalyst/Imnovid, prescribed for multiple myeloma patients; and Orencia, targeting active rheumatoid arthritis and psoriatic arthritis in adults.